Home » Topics » BioWorld Science

BioWorld Science
RSS

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Targretin clinical trials update

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

AG-3340 on track for clinical testing

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Milkhaus to initiate phase I testing of LDI-200 in solid tumors

May 3, 1996

Efficacy data for Gonadimmune reported at AACR

May 3, 1996

Somatix receives patent coverage for GVAX

May 3, 1996

MTP-5019 data revealed at AACR

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...